$2.00
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

TherapeuticsMD, Inc. operates as a pharmaceutical company. The company is headquartered in Boca Raton, Florida and currently employs 1 full-time employees. The company went IPO on 2001-01-31. The company receives royalties on products licensed to pharmaceutical organizations that possess commercial capabilities in the relevant territories. The company granted a license to commercialize IMVEXXY, BIJUVA, and prescription prenatal vitamin products sold under the BocaGreenMD and vitaMedMD brands and assigned its exclusive license to commercialize ANNOVERA to Mayne Pharma. IMVEXXY (estradiol vaginal inserts) pharmaceutical product is for the treatment of moderate-to-severe dyspareunia. BIJUVA pharmaceutical product is a Food and Drug Administration (FDA)-approved bioidentical hormone therapy combination of estradiol and progesterone in a single, oral capsule for the treatment of moderate-to-severe vasomotor symptoms due to menopause in women with a uterus. ANNOVERA pharmaceutical product is a one-year ring-shaped contraceptive vaginal system (CVS).
Country

US

CEO

Mr. Marlan Walker

IPO date

2001

Employees

1

ISIN

US88338N2062

Key stats

Open

$2.00

Volume

42.88K

Market cap

$23.26M

Prev. close

$2.00

Impl / hst vl

-

Open interest

$0.00

$2.00

Day’s Range

$2.06

$1.58

52W Range

$2.95

Valuation

44
Valuation score
Fairly Valued
P/E
-
P/S
6.85
P/B
0.85
Current ratio
3.11
Debt / Equity
-0.31
ROE
0.66%
Gross margin
-
Income growth
-115.35%
FCF growth
154.35

Analysts estimates

Consensus rating
Hold

The average rating from top 3 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$5.10
The top 3 analysts forecasts that 12-month price may increase by 155.00%, with a low of $5.05 and a high of $5.25
$5.05
Low
$5.10
Avg
$5.25
High
Current price

Earnings

Q1 ‘26 revenue
$724.00K
Q1 ‘26 net income
$95.00K
Revenue
Net income
Previous EPS
-
Estimate EPS
$0.00
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply